Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Barve · SciRah

Researcher profile · Semantic Scholar

A. Barve

Share profile

A. Barve — researcher profile on SciRah

h-index: 12
Works: 38
Citations: 1,265

Most-cited papers

Ligelizumab for Chronic Spontaneous Urticaria.
M. Maurer, A. Giménez-Arnau, G. Sussman, M. Metz +23 more
2019New England Journal of Medicine205 citations Open access
Semantic Scholar
Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats
A. Barve, Chi Chen, V. Hebbar, J. Desiderio +2 more
2009Biopharmaceutics & drug disposition202 citations Open access
Semantic Scholar
Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models
K. Kwon, A. Barve, Si-Wang Yu, Mou-Tuan Huang +1 more
2007Acta Pharmacologica Sinica158 citations
Semantic Scholar
γ-Tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice
A. Barve, Tin Oo Khor, S. Nair, K. Reuhl +4 more
2009International Journal of Cancer137 citations Open access
Semantic Scholar
Pharmacokinetics and Pharmacodynamics of Broccoli Sprouts on the Suppression of Prostate Cancer in Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Mice: Implication of Induction of Nrf2, HO-1 and Apoptosis and the Suppression of Akt-dependent Kinase Pathway
Y. Keum, Tin Oo Khor, Wen Lin, Guoxiang Shen +4 more
2009Pharmaceutical Research117 citations
Semantic Scholar
Murine Prostate Cancer Inhibition by Dietary Phytochemicals—Curcumin and Phenyethylisothiocyanate
A. Barve, T. Khor, X. Hao, Y. Keum +3 more
2008Pharmaceutical Research91 citations Open access
Semantic Scholar
Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells
S. Nair, A. Barve, T. Khor, G. Shen +4 more
2010Acta Pharmacologica Sinica84 citations Open access
Semantic Scholar
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Marcus Maurer, L. Ensina, A. Giménez-Arnau, G. Sussman +32 more
2023The Lancet54 citations
Semantic Scholar
Mixed Tocotrienols Inhibit Prostate Carcinogenesis in TRAMP Mice
A. Barve, T. Khor, K. Reuhl, Bandaru S. Reddy +2 more
2010Nutrition and Cancer43 citations
Semantic Scholar
Pharmacogenomic profile of soy isoflavone concentrate in the prostate of Nrf2 deficient and wild-type mice.
A. Barve, T. Khor, S. Nair, Wen Lin +4 more
2008Journal of Pharmacy and Science42 citations
Semantic Scholar
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study
M. Maurer, A. Giménez-Arnau, J. Bernstein, Chia-Yu Chu +14 more
2021Allergy. European Journal of Allergy and Clinical Immunology38 citations Open access
Semantic Scholar
Drug‐Drug Interaction Studies With Oral Contraceptives: Pharmacokinetic/Pharmacodynamic and Study Design Considerations
Hai-Ying Sun, R. Sivasubramanian, S. Vaidya, A. Barve +1 more
2020Journal of clinical pharmacology28 citations
Semantic Scholar
Physiologically based pharmacokinetic modeling for assessing the clinical drug-drug interaction of alisporivir.
Binfeng Xia, A. Barve, Tycho Heimbach, Tao Zhang +9 more
2014European Journal of Pharmaceutical Sciences12 citations
Semantic Scholar
Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes.
Birk Poller, R. Woessner, A. Barve, H. Tillmann +7 more
2019Pulmonary Pharmacology & Therapeutics10 citations
Semantic Scholar
Nrf2-mediated antioxidant and detoxifying enzyme induction by a combination of curcumin and sulforaphane
F. Fuentes, Yury Y. Gomez, Ximena Paredes-Gonzalez, A. Barve +4 more
20168 citations
Semantic Scholar
Clinical Exposure Boost Predictions by Integrating Cytochrome P450 3A4-Humanized Mouse Studies With PBPK Modeling.
Jin Zhang, Tycho Heimbach, N. Scheer, A. Barve +3 more
2016Journal of Pharmacy and Science6 citations
Semantic Scholar
The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans
A. Barve, S. J. Kovacs, J. Ke, R. Crabbé +9 more
2015Clinical pharmacology in drug development6 citations
Semantic Scholar
Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria: Results from the Phase-3 Pivotal Trials
L. Ensina, J. Bernstein, G. Sussman, M. Maurer +7 more
2023Journal of Allergy and Clinical Immunology5 citations
Semantic Scholar
Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
M. Metz, J. Bernstein, A. Giménez-Arnau, M. Hide +9 more
2022The World Allergy Organization Journal5 citations Open access
Semantic Scholar
Long-term treatment with ligelizumab achieves prolonged symptom control during the post-treatment follow-up
W. Soong, J. Bernstein, G. Sussman, B. Lanier +7 more
20205 citations Open access
Semantic Scholar
Pharmacokinetics, Pharmacodynamics and Drug Metabolism
A. Barve, T. Khor, S. Nair, Wen Lin +4 more
20085 citations
Semantic Scholar
Sa1081 Therapeutic Dose Effects of the Cyclophilin Inhibitor Alisporivir (ALV) on Circulating Bilirubin Concentrations in Healthy Subjects
S. J. Kovacs, J. Ke, Kristina Dabovic, A. Barve +1 more
20122 citations
Semantic Scholar
P68: Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate‐to‐severe AD
J. Bernstein, M. Maurer, A. Gim, enez-Arnau +21 more
2021British Journal of Dermatology1 citations Open access
Semantic Scholar
P153 COMPLETE CONTROL OF URTICARIA SYMPTOMS WITH LIGELIZUMAB HELPS NORMALIZE QUALITY OF LIFE
J. Bernstein, M. Maurer, A. Giménez-Arnau, W. Soong +6 more
20201 citations
Semantic Scholar
Impact of co-administration of fevipiprant (QAW039) and SLCO1B1 genotype on the PK of simvastatin and rosuvastatin
A. Barve, H. Tillmann, E. Ilsley, Janardhana Vemula +6 more
20161 citations
Semantic Scholar
P710 EFFECT OF ALISPORIVIR (ALV) ON THE PHARMACOKINETICS (PK), SAFETY, AND TOLERABILITY OF METHADONE IN HEALTHY SUBJECTS AND OPIOID-DEPENDENT PATIENTS ON STABLE METHADONE MAINTENANCE THERAPY (MMT)
S. J. Kovacs, J. Ke, A. Barve, L. Webster +5 more
20141 citations
Semantic Scholar
840 EFFECT OF THERAPEUTIC DOSES OF ALISPORIVIR (ALV) ON METHADONE PHARMACOKINETICS IN HEALTHY SUBJECTS AND PATIENTS ON STABLE METHADONE MAINTENANCE THERAPY (MMT)
S. J. Kovacs, J. Ke, A. Barve, Y. Cheng +4 more
20131 citations Open access
Semantic Scholar
P66: Prolonged symptom control with long‐term ligelizumab treatment in patients with chronic spontaneous urticaria during post‐treatment follow‐up
J. Bernstein, G. Sussman, M. Metz, B. Lanier +14 more
2021British Journal of Dermatology0 citations Open access
Semantic Scholar
27362 High rate of complete response achieved with ligelizumab in patients with moderate to severe chronic spontaneous urticaria throughout the phase 2b core study
J. Bernstein, M. Maurer, A. Giménez-Arnau, W. Soong +6 more
20210 citations
Semantic Scholar
P65: Retrospective analysis of the safety and appropriate use of 2,3‐diphenylcyclopropenone in alopecia in a university teaching hospital
Z. Haider, A. Abdullah, W. Soong, J. Bernstein +10 more
2021British Journal of Dermatology0 citations
Semantic Scholar
P67: High rate of complete response with ligelizumab in adults with moderate‐to‐severe chronic spontaneous urticaria
J. Bernstein, M. Maurer, A. Gim, enez-Arnau +21 more
2021British Journal of Dermatology0 citations
Semantic Scholar
D100 LIGELIZUMAB ACHIEVES FAST CONTROL OF SYMPTOMS IN MORE PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA VERSUS OMALIZUMAB
T. Severin, W. Soong, M. Maurer, A. Giménez-Arnau +5 more
20200 citations
Semantic Scholar
A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteers
S. Youngberg, Erin Brandt, A. Barve, Surendra Machineni +4 more
2018Journal of Drug Assessment0 citations Open access
Semantic Scholar
The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter Trial.
E. Lawitz, M. Bidair, T. Marbury, Christopher T. Jones +20 more
2018Clinical Therapeutics0 citations
Semantic Scholar
Sa1031 Mild to Moderate Hepatic Impairment Has No Effect on the Single Dose Pharmacokinetics of Alisporivir (ALV)
S. J. Kovacs, J. Ke, J. Praestgaard, A. Barve +4 more
20130 citations
Semantic Scholar
841 THE EFFECT OF MILD TO MODERATE HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF ALISPORIVIR (ALV)
S. J. Kovacs, J. Ke, J. Praestgaard, A. Barve +4 more
20130 citations Open access
Semantic Scholar
Prevention of Oxidative Stress–Induced Diseases by Natural Dietary Compounds: The Mechanism of Actions
T. Khor, Ka Cheung, A. Barve, H. Newmark +1 more
20100 citations
Semantic Scholar
PROSTATE CANCER CHEMOPREVENTION BY DIETARY PHYTOCHEMICALS
A. Barve
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Severin×13
Invite
T. Severin — researcher profile on SciRah
E. Hua×12
Invite
E. Hua — researcher profile on SciRah
R. Janocha×10
Invite
R. Janocha — researcher profile on SciRah
A. Giménez-Arnau×9
Invite
A. Giménez-Arnau — researcher profile on SciRah

×9

Invite

K. Sitz — researcher profile on SciRah

Invite

A. Kong — researcher profile on SciRah

Invite

W. Soong — researcher profile on SciRah

Invite

M. Maurer — researcher profile on SciRah

Invite

M. Metz — researcher profile on SciRah

J. Bernstein×7

Invite

J. Bernstein — researcher profile on SciRah

Invite

J. Ke — researcher profile on SciRah

S. J. Kovacs×7

Invite

S. J. Kovacs — researcher profile on SciRah